HAVCR2 and melanoma: Notably, it was shown that PD-1 and Tim-3 limited the expansion of tumor Ag-specific CD8+ T cells induced by a melanoma peptide vaccine, as dual blockade enhanced the expansion and cytokine production of vaccine-induced CD8+ T cells in vitro (44).